Skip to main content

Table 3 (including only HA-VRE from clinical specimen). Results of multivariable analysis for the frequency of hospital-acquired vancomycin resistant enterococci cases with antibiotic use by antibiotic group (ATC-code 5-digit)

From: The effect of antibiotic use on prevalence of nosocomial vancomycin-resistant enterococci- an ecologic study

Parameter/category

IRR

95% CI

p-value

Ward

 Medical ward

1 = reference

  

 Hematological/oncological ward

1.38

0–60-3.19

0.451

 Intensive care unit

4.7

2.02–10.96

<.0001

 Surgical ward

1.24

0.55–2.83

0.594

Patient with community-acquired VRE on ward in the current month

1.77

1.19–2.63

0.005

Glycopetide (J01XA) use in the previous month (per 1 DDD/100 patient-days)

1.03

1.01–1.05

0.0038

Year 2015 (compared to 2014)

1.40

1.05–1.86

0.005

  1. DDD Defined daily dose; IRR Incidence rate ratio; CI Confidence interval